Dutasteride

Dutasteride has been studied in 6 papers since 2016: 5 observational studies in people, 1 review; 2 in the past year. It is an approved medicine. The newest paper, Mar 31, 2026: “Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study”.

InterventionApproved 2001

6 papers study it5 more mention it8 findingsUpdated

PubChemChEBIMeSH

See all 11 papers on dutasteride

At a glance

The findings reach people, from one lab or study. 4 independent labs in 5 countries; 59 trials, 1 about aging, 24 with no results posted.

“Men taking finasteride or dutasteride were at increased risk of all-cause dementia”
Association of 5α-Reductase Inhibitors With Dementia, Depression, and SuicideJAMA network open2022doi:10.1001/jamanetworkopen.2022.48135

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 4 independent labs in 5 countries
  • 59 trials, 1 about aging, 24 with no results posted
  • Funders: Forskningsrådet för hälsa, arbetsliv och välfärd and others
  • 3 of 8 findings with company ties
  • Humans5

What did studies of dutasteride find?

5

Studies of dutasteride measured 5 outcomes, among them type 2 diabetes, suicide and stroke.

Type 2 diabetes

no changein humans1HR 0.97

1 study
  1. Dutasteride was not clearly linked with type 2 diabetes in humans (benign prostatic hyperplasia) (HR 0.97, 95% CI 0.92-1.02).

    “that for dutasteride was 0.97 (95% CI, 0.92-1.02), when compared with tamsulosin users”

    Humansbenign prostatic hyperplasiaat least 90 days

    Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study

    Yonsei medical journal

More on Type 2 diabetes

Suicide

no changein humans1HR 0.98

1 study
  1. Dutasteride was not clearly linked with suicide in humans (HR 0.98, 95% CI 0.62-1.54).

    “In contrast, 5-ARIs were not associated with suicide (finasteride: HR, 1.22 [95% CI, 0.99-1.49]; dutasteride: HR, 0.98 [95% CI, 0.62-1.54]).”

    Humansmales

    Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide

    JAMA network open

Stroke

no changein humans1HR 1.03

1 study
  1. Dutasteride was not clearly linked with stroke in humans (relative to finasteride) (HR 1.03, 95% CI 0.88-1.20).

    “Similarly, we found no difference in the risk of acute myocardial infarction (HR 0.94, 95% CI 0.82-1.08) or stroke (HR 1.03, 95% CI 0.88-1.20).”

    Humansrelative to finasteridemales

    The Cardiovascular Safety of Dutasteride

    The Journal of urology

More on Stroke

Acute myocardial infarction

no changein humans1HR 0.94

1 study
  1. Dutasteride was not clearly linked with acute myocardial infarction in humans (relative to finasteride) (HR 0.94, 95% CI 0.82-1.08).

    “Similarly, we found no difference in the risk of acute myocardial infarction (HR 0.94, 95% CI 0.82-1.08) or stroke (HR 1.03, 95% CI 0.88-1.20).”

    Humansrelative to finasteridemales

    The Cardiovascular Safety of Dutasteride

    The Journal of urology

More on Acute myocardial infarction

Hospitalization for heart failure

no changein humans1HR 0.98

1 study
  1. Dutasteride was not clearly linked with hospitalization for heart failure in humans (relative to finasteride) (adjusted HR 0.98, 95% CI 0.88-1.08).

    “we found no difference in the risk of heart failure among patients receiving dutasteride relative to those receiving finasteride”

    Humansrelative to finasteridemales

    The Cardiovascular Safety of Dutasteride

    The Journal of urology

What is dutasteride linked with?

3

Studies link dutasteride with 3 measures: age-related macular degeneration, depression and all-cause dementia.

Age-related macular degeneration

upin humans1HR 1.13

1 study
  1. Dutasteride is linked with a higher risk of age-related macular degeneration in humans (benign prostate hyperplasia (BPH) patients in subgroup analysis) (HR: 1.13; 95% CI: 1.02-1.25).

    “increased risk of incident age-related macular degeneration was observed in patients receiving dutasteride [HR: 1.13; 95% CI: 1.02-1.25]”

    Humansbenign prostate hyperplasia (BPH) patients in subgroup analysismean follow-up of 3.7 yearsmales

    Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study

    Age and ageing

More on Age-related macular degeneration

Depression

upin humans1HR 1.68

1 study
  1. Dutasteride is linked with a higher risk of depression in humans (HR 1.68, 95% CI 1.43-1.96; constant risk over time).

    “Both finasteride and dutasteride were similarly associated with depression with a constant risk over time”

    Humansmales

    Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide

    JAMA network open

More on Depression

All-cause dementia

upin humans1HR 1.1

1 study
  1. Dutasteride is linked with a higher risk of all-cause dementia in humans (HR 1.10, 95% CI 1.01-1.20).

    “Men taking finasteride or dutasteride were at increased risk of all-cause dementia”

    Humansmales

    Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide

    JAMA network open

More on All-cause dementia

Has dutasteride been tested in people?

1 of 59 about aging

Yes: 5 observational studies in people have been published, and 59 trials are registered.

About aging

Approved

Every condition in trials

  • Prostatic hyperplasia

    Phase 4Results posted24 trials

  • Prostatic neoplasm

    Phase 4Results posted17 trials

  • Alcoholism

    Phase 4Results posted2 trials

  • Alopecia

    Phase 3Results posted2 trials

  • Hyperplasia

    Phase 3Terminated1 trial

  • Physiological sexual dysfunction

    Phase 3Status unknown1 trial

All 17

Stopped

  • NCT00421421TerminatedProstatic hyperplasia

    Incomplete information

  • NCT01673490TerminatedProstatic hyperplasia

    The sole investigative site refused to accept the amended protocol and declined to continue the study. There was no safety signal nor any other reason.

  • NCT00431626TerminatedHyperplasia

    Low enrollment

Trial sponsors

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 03 papers in 12 months

See all 11 papers on dutasteride